European Watchdog Partially Approves New Alzheimer’s Drug
Amsterdam: Europe’s medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer’s disease, reversing an earlier decision not to give it the green light. “After re-examining its initial opinion, the EMA… has recommended granting marketing authorisation to Leqembi (lecanemab) for treating mild cognitive impairment or mild dementia due to…
Read More “European Watchdog Partially Approves New Alzheimer’s Drug” »